Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Cerevel starts dosing volunteers in phase I study of CVL-936

Jan. 31, 2020

Snake venom organoid gives toxin insights

Jan. 30, 2020

Idorsia Pharmaceuticals discovers OX1/OX2 receptor antagonists

Jan. 29, 2020

Results from GLP preclinical study of AAV8-hCocH gene therapy

Jan. 22, 2020

Cobra genome may yield new antivenoms, venom-based drugs

Jan. 8, 2020

Opiant signs letter of intent with NCATS to collaborate on OPNT-004 development

Jan. 3, 2020

Trial to evaluate Trevena's TRV-734 for opioid use disorder

Dec. 24, 2019

Embera NeuroTherapeutics receives funding to advance EMB-001 into phase II studies

Dec. 20, 2019

Indivior selects CRO to conduct phase I study of INDV-2000

Dec. 10, 2019

Adamis Pharmaceuticals receives a complete response letter regarding Zimhi

Nov. 26, 2019